3-[(2s)-2-{[(4-methylphenyl)sulfonyl]amino}-3-oxo-3-piperidin-1-ylpropyl]benzenecarboximidamide (0ZG) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.11
Number of clusters 32
Number of clusters representing 95% 10
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 1.7079
ΔGstrain (kcal/mol) 0.9537
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 2798 0 3.0176
2 1452 0.3884 3.0681
3 1268 0.4686 2.1404
4 1112 0.5464 3.0218
5 1066 0.5714 2.1091
6 559 0.9537 1.2121
7 490 1.0317 1.8639
8 326 1.2730 2.9839
9 258 1.4115 3.6005
10 162 1.6871 2.6712
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)